Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.430
+0.010 (0.70%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $67.37 million as of April 29, 2025. Its market cap has decreased by -48.98% in one year.
Market Cap
67.37M
Enterprise Value
665.70K
1-Year Change
-48.98%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $67.37M, a decrease of -91.62%. That is a compound annual growth rate of -44.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 66.90M | -24.07% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |